Science Explorer Interactive view Map
Company · Courbevoie · France

IQVIA (France)

World rank, 2022–2025
#25,914
of 28,054 · #38,016 all time
Rank in France
#1,262
of 1,422
Research works
160
▲ 144% vs 2013–17
Citations
1.3k
8.4 per fractional work
Top-10% rate
7.0%
record average 16.5%
Open access
47%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.07× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.36× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 5.08× its world share, 3 worksImmunology and Micro…Neuroscience: 0.17× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.99× its world share, 1 worksPharmacology, Toxico…Computer Science: 0.15× its world share, 1 worksComputer ScienceEngineering: 0.04× its world share, 0 worksEngineeringEnvironmental Science: 0.20× its world share, 1 worksEnvironmental ScienceMathematics: 0.96× its world share, 1 worksMathematicsPhysics and Astronomy: 0.07× its world share, 0 worksPhysics and AstronomyDentistry: 0.22× its world share, 0 worksDentistryHealth Professions: 3.15× its world share, 5 worksHealth ProfessionsMedicine: 2.51× its world share, 31 worksMedicineArts and Humanities: 0.02× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.30× its world share, 1 worksBusiness, Management…Decision Sciences: 0.74× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 11.94× its world share, 16 worksEconomics, Econometr…Psychology: 0.90× its world share, 2 worksPsychologySocial Sciences: 0.04× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Economics, Econometrics and Finance, 11.9×. Every wedge is a field page.

Which keywords describe research at IQVIA (France)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Epidemiology, Primary Care, Public Health, Pharmaceutical Industry and Healthcare Quality Indicators.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Quality of Life12▲ 13×13 topics
  2. Epidemiology10▲ 4.0×51 topics
  3. Cost-effectiveness Analysis9▲ 162×1 topic
  4. Health Utility Measures9▲ 162×1 topic
  5. Public Health5▲ 5.3×10 topics
  6. Primary Care5▲ 20×5 topics
  7. Pharmaceutical Industry4▲ 150×2 topics
  8. Healthcare Quality Indicators3▲ 89×2 topics
  9. Healthcare Policy3▲ 55×1 topic
  10. Inequalities3▲ 149×1 topic
  11. Drug Development Costs3▲ 194×1 topic
  12. Generic Drugs3▲ 194×1 topic
  13. Inflammation3▲ 2.2×17 topics
  14. Clinical Trials3▲ 6.5×11 topics
  15. Treatment3▲ 3.4×15 topics
  16. Cost of Care2▲ 133×1 topic
  17. Depression2▲ 4.4×7 topics
  18. Financial Toxicity2▲ 133×1 topic
  19. Anxiety2▲ 7.8×7 topics
  20. Diagnosis2▲ 4.0×14 topics
  21. Autoantibodies2▲ 13×7 topics
  22. Cardiovascular Disease2▲ 2.7×10 topics
  23. Management2▲ 3.8×8 topics
  24. Risk Factors2▲ 2.7×10 topics
  25. Pathogenesis2▲ 5.3×9 topics
  26. Global Burden2▲ 4.8×6 topics
  27. Heart Failure2▲ 5.3×8 topics
  28. Clinical Guidelines1▲ 7.4×5 topics
  29. Clinical Practice Guidelines1▲ 4.0×5 topics
  30. Healthcare Workers1▲ 8.1×2 topics
  31. Psychological Distress1▲ 7.9×2 topics
  32. Asthma1▲ 19×2 topics
  33. Health Care Utilization1▲ 16×2 topics
  34. Psychological Impact1▲ 5.9×2 topics
  35. Quarantine1▲ 12×1 topic
  36. Social Isolation1▲ 9.2×1 topic
  37. Cancer Survivorship1▲ 24×2 topics
  38. Clinical Outcomes1▲ 8.3×5 topics
  39. Health-related Quality of Life1▲ 7.1×3 topics
  40. Respiratory1▲ 17×2 topics

Which research topics does IQVIA (France) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Healthcare Systems and Practices, Pharmaceutical Economics and Policy and Economic and Financial Impacts of Cancer.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 9 works
  2. 2 Healthcare Systems and Practices General Health Professions 3 works
  3. 3 Pharmaceutical Economics and Policy Economics and Econometrics 3 works
  4. 4 Economic and Financial Impacts of Cancer Economics and Econometrics 2 works
  5. 5 COVID-19 and Mental Health Clinical Psychology 1 works
  6. 6 Healthcare Policy and Management Economics and Econometrics 1 works
  7. 7 Cancer survivorship and care Oncology 1 works
  8. 8 Bacterial Infections and Vaccines Microbiology 1 works
  9. 9 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 1 works
  10. 10 Asthma and respiratory diseases Physiology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.3%not open52.7%

World: 28% of research is openly available.

with international co-authors47.5%domestic only52.5%

World: 19% is written across borders.

How has IQVIA (France)'s research output changed?

Output in 2018–2022 was 144% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Courbevoie

All research institutions in Courbevoie

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.